Thoracoscopic Sympathectomy for Blushing. A Prospective Randomised Trial.
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Odense University Hospital
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- Effect of operation. Side effects: compensatory and gustatory sweating.
Study Overview
Brief Summary
To determine outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing and investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy.
Detailed Description
To determine the outcome and side effects following thoracoscopic sympathectomy in patients treated for disabling isolated facial blushing. In addition, following randomization investigate if there are any significant differences between two different routine procedures: T2 or T2-T3 sympathectomy. Includes QoL before and 12 months after surgery
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 18 Years to 70 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Isolated disabling facial blushing
- •Over 18 years of age
- •Willing to be randomized
Exclusion Criteria
- •Primary hyperhidrosis in palms or axillae
- •Previous lung surgery
- •Bradycardia
- •Arrythmias
- •Pregnancy
Arms & Interventions
1
T2 sympathectomy
Intervention: Level of sympathectomy (Procedure)
2
T2-T3 sympathectomy
Intervention: Level of sympathectomy (Procedure)
Outcomes
Primary Outcomes
Effect of operation. Side effects: compensatory and gustatory sweating.
Time Frame: 12 months after surgery
Secondary Outcomes
No secondary outcomes reported
Investigators
Peter B Licht
Professor
Odense University Hospital